Understanding Hemophilia a Disease: A Complete Patient Guide

Hemophilia A disease is a lifelong bleeding disorder in which the blood does not have enough clotting factor VIII, a protein needed to form stable clots. With specialist care, preventive treatment and a personal bleeding plan, many people with hemophilia A can lead active and fulfilling lives.

Overview: What Is Hemophilia A Disease?

Hemophilia A disease, also called factor VIII deficiency, is an inherited condition that affects the body’s ability to stop bleeding. When a blood vessel is injured, clotting proteins work together in a sequence to create a stable blood clot. People with hemophilia A have too little functioning factor VIII, so this process is less effective and bleeding may last longer than expected.

Hemophilia A does not mean that a person bleeds faster from every small cut. Minor surface cuts may often be manageable with usual first aid. The more important concern is prolonged bleeding after injury, dental work or surgery, and bleeding into joints, muscles or internal tissues. Internal bleeding is not always visible, which is why recognizing symptoms and following an individualized treatment plan matters.

The condition is most often diagnosed in males because it is linked to the X chromosome. However, females who carry a change in the factor VIII gene may also have low factor levels and clinically significant bleeding. Hemophilia A is different from hemophilia B, which involves a deficiency of factor IX, although their symptoms can be similar.

How Severity and Symptoms Can Differ

Doctors classify hemophilia A as mild, moderate or severe according to the amount of factor VIII activity in the blood. People with severe hemophilia A may have spontaneous bleeding, meaning bleeding that begins without a clear injury. Those with mild hemophilia A may not be diagnosed until they have unusual bleeding after a major injury, surgery, tooth extraction or childbirth.

Bleeding into joints, especially the ankles, knees and elbows, is a characteristic symptom. A joint bleed can cause tingling, warmth, swelling, pain, stiffness or reduced movement. Repeated bleeding in the same joint can damage cartilage over time and may lead to chronic pain or reduced mobility if it is not prevented and treated promptly.

Other possible symptoms include large or unexplained bruises, prolonged nosebleeds, bleeding from the mouth, blood in urine or stool, prolonged bleeding after injections, and deep muscle bruising or swelling. Babies and young children may be diagnosed after bruising becomes noticeable during crawling or walking, or after prolonged bleeding from a medical procedure.

• Possible joint bleed: warmth, tightness, pain, swelling or reluctance to use a limb.
• Possible muscle bleed: deep pain, swelling, numbness, weakness or reduced movement.
• Possible internal bleeding: severe headache, vomiting, confusion, abdominal pain, black stools or blood in urine.

Causes, Inheritance and Risk Factors

Hemophilia A results from a change, also called a variant or mutation, in the F8 gene. This gene provides instructions for making factor VIII. Most cases are inherited through families in an X-linked pattern. A person with an altered F8 gene can pass it on to children, but the chance of inheritance depends on the biological sex of the parent and child and the family’s specific genetic pattern.

Some people diagnosed with hemophilia A have no known family history. In these cases, the genetic change may have occurred for the first time in that person or in a recent generation. A bleeding history in male relatives can be helpful, but its absence does not rule out the condition.

Rarely, a person develops hemophilia A later in life because the immune system produces antibodies that interfere with factor VIII. This is called acquired hemophilia A and is not inherited. It can occur in association with pregnancy, autoimmune disease, cancer, certain medicines or no identifiable cause. New, unexplained and significant bleeding in someone without a previous bleeding history requires urgent medical assessment.

Diagnosis and Ongoing Monitoring

Diagnosis begins with a careful discussion of bleeding symptoms, medical procedures, medicines and family history. A clinician may ask about frequent bruising, prolonged bleeding after dental work, heavy menstrual bleeding, postpartum bleeding, joint symptoms and bleeding in relatives. Because symptoms can vary, normal day-to-day health does not exclude a mild bleeding disorder.

Blood tests assess how long blood takes to clot and measure factor VIII activity. Tests may include an activated partial thromboplastin time, known as APTT, along with specific clotting factor assays. Genetic testing may help confirm the inherited cause, identify carrier status in family members and support reproductive counseling when desired.

People receiving factor VIII treatment are monitored for inhibitors. Inhibitors are antibodies that can develop against infused factor VIII and make replacement treatment less effective. Testing is particularly important when bleeding is harder to control than expected or when a person has recently started factor treatment. Care is ideally coordinated through a hemophilia treatment center or a specialist team with experience in bleeding disorders.

Treatment Options and a Personal Bleeding Plan

Treatment is tailored to the person’s factor level, bleeding pattern, age, lifestyle, access to care and presence of inhibitors. The central aim is to prevent bleeds where possible, treat bleeds early and protect long-term joint health. A hematologist can help create a written plan explaining which treatment to use, when to use it and when emergency care is needed.

Factor VIII replacement therapy provides the missing clotting factor. It may be given to treat a bleed, before surgery or dental procedures, or regularly as prophylaxis to prevent bleeding. Some people use standard half-life factor products, while others use extended half-life products that remain active for longer. The choice is individualized and should be reviewed regularly with the treatment team.

Non-factor therapies may also be used to prevent bleeding in suitable people, including some individuals with factor VIII inhibitors. Additional medicines that help stabilize blood clots can be useful for selected mouth, nose or menstrual bleeding episodes and for certain procedures. Desmopressin may be considered for some people with mild hemophilia A because it can temporarily raise factor VIII levels, but it is not suitable for everyone or every situation.

Gene therapy has become an option for selected adults with severe hemophilia A in some healthcare settings. It is not appropriate for all patients, and eligibility, possible benefits, uncertainties and long-term monitoring requirements should be discussed in detail with a specialist. If inhibitors are present, treatment may involve bypassing agents and immune tolerance induction, which aims to reduce or remove the inhibitor over time.

Daily Life, Prevention and Self-Care

Preventive care supports independence and helps reduce avoidable bleeding. Regular follow-up, home-treatment education when appropriate, vaccinations and dental care are important parts of long-term management. People should tell dentists, surgeons, emergency clinicians and other healthcare professionals about hemophilia A before procedures, as a treatment plan may be needed in advance.

Physical activity is generally encouraged because strong muscles can help support and protect joints. Low-impact or appropriately supervised activities, such as swimming, walking, cycling and strength exercises planned with a physiotherapist, may be suitable for many people. Contact sports and activities with a high risk of head injury may require individualized advice, protective equipment or avoidance depending on the person’s severity and treatment plan.

Some medicines can increase bleeding risk. Aspirin and many nonsteroidal anti-inflammatory drugs, such as ibuprofen, may not be appropriate unless a clinician who understands the person’s bleeding disorder advises their use. For pain, fever or inflammation, the safest option depends on the individual, so it is sensible to ask a healthcare professional or pharmacist before taking a new medicine, supplement or herbal product.

Medical identification jewelry or a digital medical alert can be useful in emergencies. Keeping treatment details available, carrying emergency contact information while traveling and ensuring sufficient medication supplies can provide reassurance. Emotional support, patient organizations and genetic counseling can also help individuals and families manage practical questions about school, work, relationships and family planning.

When to Seek Medical Care

Anyone with hemophilia A should follow their own bleeding plan and contact their hemophilia team promptly when a possible bleed occurs. Early treatment can reduce pain, limit joint damage and lower the chance that a small bleed becomes more serious. New swelling, persistent pain, reduced joint movement or unexplained bruising should not be ignored.

Urgent emergency assessment is needed after a head injury, even if the person initially seems well, because bleeding inside the skull may not be visible. Emergency care is also important for severe or worsening headache, repeated vomiting, confusion, unusual drowsiness, weakness, seizures, neck pain, severe abdominal or back pain, chest pain, breathing difficulty, or bleeding that does not respond to the prescribed plan.

Seek urgent advice for signs of a serious muscle bleed, including rapidly increasing swelling, numbness, tingling, pale or cold fingers or toes, loss of strength, or severe pain. Bleeding in the throat, tongue or neck can affect breathing and should be treated as an emergency. People with new unexplained bleeding who have never been diagnosed with a bleeding disorder should also be assessed without delay.

Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals support international patients who need assessment and treatment planning for hemophilia and other complex bleeding disorders. Ongoing care should remain coordinated with a qualified hematology team familiar with the person’s individual treatment needs.

Frequently asked questions

Is hemophilia A disease curable?

Hemophilia A is usually a lifelong inherited condition, but effective treatments can prevent and control bleeding. Some eligible adults may be considered for gene therapy in settings where it is available, although this requires careful specialist assessment and long-term follow-up. A hematologist can explain which options are appropriate for an individual.

Can females have hemophilia A?

Yes. Although hemophilia A is more commonly diagnosed in males, females can have low factor VIII levels and bleeding symptoms. A woman or girl with a family history of hemophilia, heavy menstrual bleeding, unusual bruising or excessive bleeding after procedures should discuss testing with a clinician.

What is the difference between hemophilia A and hemophilia B?

Hemophilia A is caused by low or absent factor VIII, while hemophilia B is caused by low or absent factor IX. Both conditions can cause similar bleeding symptoms, including joint and muscle bleeding. Specific blood tests are needed to identify the type because treatment products differ.

Can a person with hemophilia A exercise safely?

Many people with hemophilia A can exercise safely and benefit from improved muscle strength, balance and joint support. The best activity depends on bleeding severity, joint health, current treatment and personal experience. A hematology team or physiotherapist can help develop a suitable plan.

What are inhibitors in hemophilia A?

Inhibitors are antibodies made by the immune system that reduce the effectiveness of infused factor VIII. They can make bleeding more difficult to manage and require specialized treatment approaches. Regular monitoring helps clinicians identify inhibitors and adjust the treatment plan early.

Should a person with hemophilia A tell a dentist before treatment?

Yes. Dental cleaning, extractions and some other procedures can cause bleeding, so the dentist should know about hemophilia A well in advance. The hematology team may recommend preventive treatment or specific local measures before and after dental care.

References

• World Federation of Hemophilia
• Centers for Disease Control and Prevention
• National Heart, Lung, and Blood Institute
• National Institute for Health and Care Excellence
• International Society on Thrombosis and Haemostasis

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.